ACTRN12618000305224尚未招募未知
An assessor blinded, parallel group randomized 12-week pilot study comparing effectiveness of the Intensive Early Active Treatment (I-EAT) program to usual care on feeding and swallowing in infants at risk of cerebral palsy
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 Months 至 12 Months（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
A randomised, assessor blind, parallel group, comparative trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion, NeutraLice Advance and Moov Head Lice Solution) After a Single Applicatiohead lice infestationSkin - Dermatological conditionsACTRN12609000884202Key Pharmaceuticals Pty. Ltd.90
已完成
4 期
A randomised, assessor blind, parallel group comparative trial of NeutraLice Lotion, NeutraLice Advance and Banlice Mousse in the treatment of head lice in childreACTRN12610000179033key Pharmaceuticals Ltd.120
进行中（未招募）
1 期
Clinical study to compare the safety and effectiveness of Actavis rhFSH (the medicine being developed) with GONAL-f (an approved medicine) in Stimulating Multiple Follicles (a woman's eggs or ova) in Women Participating in an Assisted Reproductive Technology Program (such as in vitro fertilisation, 'IVF')Stimulation of multifollicular development in women undergoingsuperovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intrafallopian transfer.MedDRA version: 17.0Level: PTClassification code 10021928Term: Infertility femaleSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2013-003788-67-GBWatson Laboratories, Inc. - A subsidiary of Actavis, Inc.471
进行中（未招募）
不适用
Clinical study to compare the safety and effectiveness of Actavis rhFSH (the medicine being developed) with GONAL-f (an approved medicine) in Stimulating Multiple Follicles (a woman's eggs or ova) in Women Participating in an Assisted Reproductive Technology Program (such as in vitro fertilisation, 'IVF')Stimulation of multifollicular development in women undergoingsuperovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intrafallopian transfer.MedDRA version: 17.0Level: PTClassification code 10021928Term: Infertility femaleSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2013-003788-67-BEWatson Laboratories, Inc. - A subsidiary of Actavis, Inc.471
进行中（未招募）
不适用
Clinical study to compare the safety and effectiveness of Actavis rhFSH (the medicine being developed) with GONAL-f (an approved medicine) in Stimulating Multiple Follicles (a woman's eggs or ova) in Women Participating in an Assisted Reproductive Technology Program (such as in vitro fertilisation, 'IVF')EUCTR2013-003788-67-ESWatson Laboratories, Inc. - A subsidiary of Actavis, Inc.400